Raymond James & Associates »

Acelyrin shares owned by Raymond James & Associates

Quarter-by-quarter ownership of Acelyrin (SLRN) shares owned by Raymond James & Associates from 13F filings

Historical chart of Raymond James & Associates investment in Acelyrin

Tip: Access up to 7 years of quarterly data

All positions including Acelyrin held by Raymond James & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acelyrin by Raymond James & Associates

Quarter filed Position value Share count Share price at filing
2024-03-31 $77k 11k 6.75
2023-12-31 $79k 11k 7.46
2023-09-30 $189k 19k 10.17